Valeant Pharmaceuticals' business model : the repercussions for patients and the health care system : hearing before the Special Committee on Aging, United States Senate, One Hundred Fourteenth Congress, second session, Washington, DC, April 27, 2016

Author / Creator

United States. Congress. Senate. Special Committee on Aging

Available as

Online

Physical